Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 68.90
+3.70 (5.67%)
Oct 21, 2025, 5:31 PM CET
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 1.1 billion as of October 21, 2025. Its market cap has decreased by -8.01% in one year.
Market Cap
1.10B
Enterprise Value
988.74M
Revenue
170.24M
Ranking
n/a
PE Ratio
20.11
Stock Price
68.90
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 194.90M to 1.10B, an increase of 463.46%. That is a compound annual growth rate of 9.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 1.10B | 7.44% |
| Dec 30, 2024 | 1.02B | 24.91% |
| Dec 29, 2023 | 818.27M | -18.39% |
| Dec 30, 2022 | 1.00B | -9.22% |
| Dec 30, 2021 | 1.10B | -10.15% |
| Dec 30, 2020 | 1.23B | 9.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 241.29B |
| Novartis AG | 201.60B |
| Lonza Group AG | 38.84B |
| Galderma Group AG | 32.86B |
| Alcon | 29.62B |
| Sandoz Group AG | 21.08B |
| Straumann Holding AG | 13.98B |
| Sonova Holding AG | 13.05B |